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t’s been 80 years since it was first noticed that workers in the
German chrome ore industry developed lung cancer more often
than the rest of the population. Study after study since the 1920s
has shown that people who work around industrial processes using
chromium have higher-than-normal rates of lung and nasal cancers.
U.S. industry has used chromium commercially for more than 100
years, and today chromium is a primary contaminant at over half of all
Superfund hazardous waste sites. But despite a century of industrial use,
there are still holes in the basic knowledge about how chromium affects
major organ systems in animals and humans, as well as the risks associ-
ated with various pathways of exposure.
Chromium occurs mainly in three forms. Metallic chromium
(Cr[0]) is a steel-gray solid with a
high melting point that’s used to
make steel and other alloys. Chrom-
ium metal does not occur naturally; it
is produced from chrome ore. Trivalent
chromium (Cr[III]) occurs naturally in
rocks, soil, plants, animals, and volcanic
emissions. This form is believed by many
to play a nutritional or pharmaceutical
role in the body, but its mechanism of action is unknown. Cr(III) is
used industrially as a brick lining for high-temperature industrial fur-
naces and to make metals, metal alloys, and chemical compounds.
Hexavalent chromium (Cr[VI]) is produced industrially when Cr(III)
is heated in the presence of mineral bases and atmospheric oxygen (for
instance, during metal finishing processes). It is this third form of
chromium that has proven to be of the greatest occupational and envi-
ronmental health concern. Cr(VI) in the Body
Cr(VI) can enter the body when people
breathe air, eat food, or drink water contain-
ing it. Cr(VI) is also found in house dust
and soil, which can be ingested or inhaled.
Of the various forms of chromium, Cr(VI)
is the most toxic. 
Certain Cr(VI) compounds have been
found to be carcinogenic in humans, but the
evidence to date indicates that the carcino-
genicity is site-specific—limited to the lung
and sinonasal cavity—and dependent on
high exposures, such as might be encoun-
tered in an industrial setting. Cr(VI) can
cause a wide range of other health effects.
Inhaling relatively high concentrations of
some forms of Cr(VI) can cause a runny
nose, sneezing, itching, nosebleeds, ulcers,
and holes in the nasal septum. Short-term
high-level inhalational exposure can cause
adverse effects at the contact site, including
ulcers, irritation of the nasal mucosa, and
holes in the nasal septum. Ingestion of very
high doses of Cr(VI) can cause kidney and
liver damage, nausea, irritation of the gas-
trointestinal tract, stomach ulcers, convul-
sions, and death. Dermal exposures may
cause skin ulcers or allergic reactions (Cr[VI]
is one of the most highly allergenic metals,
second only to nickel). And studies of mice
fed high doses of Cr(VI) have shown repro-
ductive effects including reduced litter size
and decreased fetal weight.
There is a great deal of controversy
about the relative health effects of the vari-
ous routes of exposure for Cr(VI).
According to the International Agency for
Research on Cancer (IARC), ingested
Cr(VI) is largely converted to Cr(III) in the
stomach, a fact that many chromium
experts believe prevents ingestional expo-
sures from posing significant health dangers,
since Cr(III) is not readily absorbed into the
body. The saliva, gastric juice, intestinal
bacteria, blood, liver, epithelial lining fluid,
pulmonary alveolar macrophages, peripheral
lung parynchema, and bronchial tree have
all been associated with eliminating Cr(VI)
from the body. In an article published in the
March 1997 issue of Carcinogenesis, Silvio
De Flora, director of the Department of
Health Sciences at the University of Genoa,
and colleagues present estimates of the abili-
ty of various human organs, cell popula-
tions, and fluids to reduce Cr(VI) in the
body. They found that major detoxification
is accomplished by red blood cells, with over
half of a 100-microgram (µg) dose of Cr(VI)
being sequestered or reduced by 1 milliliter
of blood within 60 minutes. De Flora and
colleagues write, “The massive reducing and
sequestering capacity of the blood explains
why [Cr(VI)] exerts its toxicological conse-
quences at the portal of entry into the
organism, while it is not a systemic toxicant
or carcinogen.”
Other experts are not convinced. In a
review article on the toxicity and carcino-
genicity of Cr(VI) in animals and humans
that was published in the September 1997
issue of Critical Reviews in Toxicology, Max
Costa, chairman of the Department of
Environmental Medicine at the New York
University Medical Center, cites studies that
have found that as much as 10% of Cr(VI) is
absorbed following oral exposure in humans.
He also references studies of occupationally
exposed subjects since the early 1980s that
estimated that 10% of absorbed Cr(VI) may
remain in the human body for up to 5 years.
Finally, Costa points to research he and col-
leagues published in the March 1993 issue of
Biological Trace Element Research, which
demonstrates that total chromium accumu-
lated in the liver, kidney, spleen, bone, lung,
heart, muscle, and blood of rats and mice
dosed orally with Cr(VI) for 4 or 8 weeks. In
his review Costa concludes, “The presence of
[chromium] in these tissues indicates a
potential for toxicity and cancer in many dif-
ferent tissues following drinking water expo-
sure to [Cr(VI)] in solution.” (This opinion
is highly controversial, however, and in a
commentary published in the April 2000
issue of Carcinogenesis, De Flora contends,
among other criticisms, that several of the
studies cited in Costa’s paper reflect an
extremely heterogeneous range of possible
exposures, some of which included agents
other than chromium.)
Because of structural similarity to phos-
phate, which is transported into all types of
cells, if Cr(VI) does reach a cell, it can enter
it. Once Cr(VI) enters the cell, it is chemi-
cally transformed to the more stable Cr(III).
This does not mean, however, that the cell
is necessarily safe from adverse effects. One
of the major reasons Cr(III) does not cause
toxic effects is that, unlike Cr(VI), it has a
poor ability to enter cells. However, inside
the cell Cr(III) has the capacity to damage
DNA. Two decades’ worth of research by
the late Karen Wetterhahn, a chemist at
Dartmouth Medical School in Hanover,
New Hampshire, and De Flora on the
uptake and reduction of Cr(VI) by cells
indicates that Cr(VI) acts as a “Trojan
horse” for delivering DNA-damaging
Cr(III) into cells.
The process by which Cr(VI) is reduced
to Cr(III) can cause many forms of DNA
damage: oxidative DNA lesions such as
strand breaks, chromium–DNA adducts,
DNA–DNA interstrand cross-links, and
DNA–protein cross-links. (An adduct is a
modification of a biological molecule—in
this case, DNA—caused by the covalent
attachment of a chemical, such as chromium;
cross-links are a specific class of adduct.)
Research by Steven Patierno, a professor of
pharmacology and genetics and of environ-
mental occupational health at The George
Washington University in Washington,
D.C., and colleagues first identified a poten-
tial mechanism of genotoxicity for intracellu-
lar Cr(III). Those studies, published in the
March 1994 issue of Molecular Carcinogenesis
and the November 1994 and July 1996
issues of Carcinogenesis, indicate that Cr(III)-
induced DNA–DNA interstrand cross-links
are the lesions responsible for blocking DNA
replication.
Recent work by Costa and colleagues
looked at the possible mutagenicity of cer-
tain Cr(III)-induced DNA adducts. In an
article published in the 15 April 1998 issue
of Nucleic Acids Research, the scientists
found that Cr(III)–glutathione cross-links
exhibited the greatest mutagenicity of the
adducts studied, with a mutation frequency
five times greater than background. This
observed mutagenicity complements other
studies on Cr(III)-dependent DNA lesions,
which demonstrate the importance of a
Cr(III)-dependent pathway in Cr(VI) car-
cinogenicity. Additional studies are investi-
gating the relative importance of oxidative
and Cr(III) pathways in genetic damage
caused by exposure to Cr(VI).
Cr(VI) in the Environment
Cr(VI) compounds are emitted into the air,
water, and soil by a number of different
industries. In the air, chromium compounds
are present mainly as fine dust particles that
eventually settle over the land and water.
The Report on Carcinogens, published by
the National Toxicology Program, says the
atmospheric total chromium concentration
in U.S. air is typically less than 0.01 µg per
cubic meter (m3) in rural areas and
0.01–0.03 µg/m3 in urban areas. Chromium
in ambient air is not regulated.
The Report on Carcinogens also indicates
that typical tap water can contain 0.4–8.0
µg per liter (L) total chromium, and that
chromium in rivers and lakes usually falls
between 1 and 10 µg/L. Cr(VI) by itself is
not regulated in drinking water. The U.S.
Environmental Protection Agency (EPA)
regulates only total chromium in drinking
water and has set a maximum contaminant
level of 100 µg/L (more stringent state limits
are often set at half that amount). 
Soil, meanwhile, contains on average
400 parts per million total chromium, but
this depends on the balance of oxidizing and
reducing agents in the soil. Chromium can
change valence state in soil and sediments
depending upon the local physical, chemi-
cal, and biological conditions. For instance,
says Paul Lioy, deputy director of the
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in soils with a high pH, Cr(III) can convert
to Cr(VI). According to the EPA’s 1998
Toxicological Review of Hexavalent Chrom-
ium, Cr(VI) found in the soil is generally
converted to Cr(III) by organic matter. Soil
concentrations are not strictly regulated by
the EPA, but rather are subject to soil
screening levels. These levels are devised on a
site-by-site basis according to the pathways
present at the site (for example, whether peo-
ple are likely to handle the soil) and certain
site characteristics (for example, whether the
soil is loamy or sandy) to determine whether
investigation or cleanup is warranted. 
The Occupational Safety and Health
Administration (OSHA) and the National
Institute for Occupational Safety and Health
(NIOSH) establish permissible exposure lim-
its (PELs) and recommended exposure limits
(RELs), respectively, for hazardous sub-
stances in the workplace. PELs are based on
the feasibility of controlling the exposure in
question within the workplace, while RELs
are based on requirements for preventing
occupational disease. Although employers are
legally bound only by PELs, they are encour-
aged by NIOSH to follow whichever limit is
the more protective. The PEL for Cr(VI) in
workplace air during an 8-hour work day,
40-hour work week is 100 µg/m3, while the
REL for carcinogenic Cr(VI) compounds in
workplace air is much lower: only 1 µg/m3. 
It has been estimat-
ed that workers in some
80 different profession-
al categories may be
exposed to Cr(VI). Var-
ious Cr(VI) compounds
are used in leather tan-
ning, the production of
textiles, dyes, and pig-
ments, and chrome
plating. Other sources
of chromium emissions
include oil and coal
combustion, stainless
steel welding, steel pro-
duction, cement plants,
industrial paint and
coating manufacture,
and cooling towers,
which use Cr(VI) as a
rust inhibitor for their
submerged moving
parts.
Occupational expo-
sures to Cr(VI) com-
pounds can be quite
acute. Although breath-
ing in Cr(VI) at con-
centrations as low as 2
µg/m3 can cause sneez-
ing and irritation of the nasal mucosa, air
concentrations of Cr(VI) compounds can get
much higher than that in certain workplace
settings. In chrome plating workshops with
local exhaust, for example, concentrations
generally range from 10 to 30 µg/m3; in
shops without local exhaust, concentrations
can climb to 120 µg/m3. Arc, stainless steel,
and alloy steel welding can produce even
higher concentrations; according to IARC,
depending on the process, welding fumes
have been found to contain concentrations as
high as 1,500 µg/m3.
NIOSH and the Agency for Toxic
Substances and Disease Registry (ATSDR)
have determined that home-based toxic
exposures can happen when people who
work in certain industries go home at night,
in what are known as worker-to-family
exposures. Family members may be exposed
to Cr(VI) and other hazardous materials
through contact with contaminated clothes,
shoes, and other items. 
Home exposures can also come from liv-
ing near hazardous waste sites. A study pub-
lished in the December 1998 issue of EHP
by Alan H. Stern, chief of the Bureau of Risk
Analysis within the New Jersey Department
of Environmental Protection, along with
Lioy and colleagues examined the relation-
ship between chromium in household dust
and chromium in the urine of residents of
Hudson County, New Jersey, which for 70
years was home to three major producers of
the Cr(VI) compound chromate. Over their
lifetime, the sites produced some two million
tons of chromium-contaminated slag, which
was used as clean fill on local residential and
commercial construction sites. In some parts
of the county, the researchers measured soil
concentrations of toxic Cr(VI) as high as sev-
eral hundred parts per million. The
researchers did not report any health effects
among the people they studied, but their
findings show that, especially for children,
the presence of chromium in household dust
correlates with urine chromium in a continu-
ous fashion. Such an effect was not present
in people who did not live near the chromate
production waste sites. Says Lioy, “Our
research . . . demonstrated that chromium
can be easily transported into the residential
house dust from outdoor sources.” The
researchers found that once the chromium-
contaminated residential soil was removed,
the chromium concentrations in the homes
were reduced over time to background levels.
Chromium can be measured in the
urine, serum, red blood cells, and whole
blood, while skin patch tests may indicate
allergies to chromium. The most common
approach to biomonitoring human exposure
to toxic metals is determining their concen-
trations in blood and urine. 
The problem with using this approach
with Cr(VI) exposure is the ubiquitous pres-
ence of nontoxic Cr(III) in food and dietary
supplements. Because Cr(VI) can convert to
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The alchemy of contamination. Chromium in the soil of this New Jersey industrial parking lot has dissolved in a pool of
standing water. Because chromium can go into solution and move through soil, chromium pools and blooms (the crystallized
chromium left on the surface when the water evaporates) may occur some distance from the original site of contamination.
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fluids could be influenced either by expo-
sure to Cr(VI) or by more benign exposures
such as eating chromium-rich food. 
However, says Stern, with proper data
collection and statistical analysis to control
for potential dietary sources of total chromi-
um exposure as well as other potential
determinants of chromium biomarker con-
centration, statistically significant differences
in chromium biomarker levels between
exposed and control populations can provide
strong evidence of exposure to environmen-
tal chromium, including Cr(VI). In industri-
al situations with high and well-documented
Cr(VI) exposure, it is generally not a prob-
lem if dietary chromium adds to blood con-
centrations. Industrial Cr(VI) exposures can
create such high blood and tissue concentra-
tions in people that the relatively low
amount of Cr(III) that most people take in
through environmental exposures is insignif-
icant in comparison, and wouldn’t affect the
ultimate diagnosis of toxic levels of exposure. 
Industry Efforts
Various industry sectors are addressing the
health risks posed to workers and the envi-
ronment by Cr(VI) as well as other toxic
compounds. The American Chemistry
Council (ACC; formerly the Chemical
Manufacturers Association), which repre-
sents members on public policy issues and
coordinates industry research and testing
programs, launched its Responsible Care
initiative in 1988 to address public concerns
about chemical manufacture and use. The
initiative offers a set of operating principles
to help participants manage chemical pro-
duction and handling more responsibly in
order to prevent on-the-job accidents,
injuries, spills, and environmental damage. 
The High Production Volume (HPV)
Chemical Challenge was designed by the
EPA, the ACC, and the Environmental
Defense Fund as a means of securing haz-
ard-screening data for more than 2,800 of
the highest-volume U.S. industrial chemi-
cals (those made or imported at more than
one million pounds per year), including
several chromium compounds. Chemical
producers and importers who agree to the
voluntary challenge will provide basic toxici-
ty data on the HPV chemicals they work
with, with a 2004 deadline to complete test-
ing for all HPV chemicals. The collaborative
effort will allow the toxicity
data gaps associated with HPV
chemicals to be filled more
quickly than the EPA could do
on its own. 
In the paint and coating
industry, federal regulations
strictly limit the use of lead
chromate pigments—which
give traffic markings their dis-
tinctive yellow color—to
industrial products like traffic
paints, finishes for machinery,
and equipment and metal
primers, says Steve Sides, vice
president of environmental
health and international affairs
for the National Paint and
Coatings Association, a Wash-
ington, D.C.–based trade orga-
nization. In fact, he says, these
pigments are banned for use in
consumer paints or on goods
manufactured for potential use
by or around children. “OSHA
regulations limit workplace
exposure to hexavalent chromi-
um,” he adds, “and that’s had a
limiting effect on their use.”
According to Sides, indus-
trial coatings manufacturers
have moved away from
Cr(VI)-containing products to
help customers meet compli-
ance obligations. “For the last
six years,” he says, “the state of
Minnesota has strictly regulated all coatings
products containing heavy metals, including
lead, mercury, cadmium, and hexavalent
chromium—a regulation the paint industry
has supported.” Sides says many state and
federal specifications for coatings, including
those issued by the Department of Defense
and the General Services Administration,
still allow the use of Cr(VI), but planned
revisions to the government specification
system may finally change this scenario.
To solicit industry input in conducting
research and setting environmental policy,
the EPA implemented the Common Sense
Initiative (CSI) in 1995 for six pilot industri-
al sectors: automobile manufacturing, com-
puters and electronics, iron and steel work,
printing, metal finishing, and petroleum
refining. Instead of addressing environmen-
tal pollution by medium—by implementing
broad regulations for air or water emis-
sions—the initiative addresses problems by
industrial sector. This means that when new
regulations are established, they are more
responsive to both the needs and the particu-
lar risks of a specific industry. As the EPA
states in its 1998 report Characterizing Risk
at Metal Finishing Facilities, “Reduced emis-
sions do not necessarily equate to a propor-
tional reduction of health risks. . . .
[R]educing emissions where there is little or
no exposure would yield a smaller health
benefit relative to reducing emissions where
there is much potential exposure. With
regards to toxicity, a large decrease in the
emission of a chemical of relatively low toxi-
city may have a smaller health benefit than a
small decrease in a more toxic compound.”
Under the CSI, subcommittees for each
industrial sector investigate ways to create
sector-specific alternatives to the current
regulatory system in the areas of pollution
prevention, reporting, compliance, permit-
ting, and environmental technology. By
creating a new regulatory system that is cus-
tomized to the specific needs and problems
of a particular industry, the EPA hopes to
encourage innovation and spur facilities to
meet or exceed legal requirements. The
Characterizing Risk report remarks that EPA
rule making has often resulted in litigation,
drawing resources away from protecting the
environment toward protecting the legisla-
tion, and says, “The EPA hopes CSI will
provide a forum within which former
adversaries will become partners in protect-
ing the environment.”
In 1997, the CSI Metal Finishing
Subcommittee published an environmental
research and development plan that sets
forth eight priority research needs as identi-
fied by metal-finishing sector stakeholders
themselves. Among the research needs are
the development and application of simple
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All in a day’s work. Occupational exposures to toxic Cr(VI)
compounds are estimated to occur in some 80 different
professional categories. Welders can receive some of the most
acute inhalational exposures.methods to assess and quantify the emis-
sions from plating operations, and the use
of these values to characterize risks to work-
ers, surrounding communities, and the
environment. The plan also calls for the
continuation and expansion of research and
development on various aspects of reducing
and eliminating air, water, and soil emis-
sions from chrome plating operations. 
Additional Research Needs
As the main federal statute for identifying
and remediating uncontrolled hazardous
waste sites, the 1980 Comprehensive
Environmental Response, Compensation,
and Liability Act (CERCLA, or Superfund)
directs the ATSDR to initiate research to fill
key data gaps for the 30 most toxic haz-
ardous substances found in Superfund sites,
a list that includes chromium. In a 1997
report titled The Toxicologic Hazard of
Superfund Hazardous Waste Sites, which
examined toxicity data for these 30 sub-
stances, the ATSDR identified the following
research needs for chromium: dose–response
data in animals for acute-duration exposure
to Cr(VI) and Cr(III) via oral exposure and
for intermediate-duration exposure to
Cr(VI) via oral exposure, a multigeneration
study of reproductive toxicity via oral expo-
sure to Cr(III) and Cr(VI), an immunotoxi-
cology battery of tests following oral expo-
sure to Cr(III) and Cr(VI), and a two-species
study of developmental toxicity via oral
exposure to Cr(III) and Cr(VI). 
Lioy adds that biomarkers for different
forms of chromium need to be validated
before use in human studies. He also says
that the levels of chromium forms need to be
detected in various media that are associated
with various routes of exposure, and that
applications of biomarkers must be coupled
to physical or chemical markers of exposures
and validated for use in situations that assess
environmental health. The report concludes
that immunotoxicity data are lacking for
most of these top 30 substances (including
chromium), and calls this “a serious deficien-
cy in knowledge needed by health and risk
assessors because of the essential role of the
immune system for protecting one’s health.”
The report also notes the paucity of research
on the dermal effects of Cr(VI).
In the ATSDR’s draft Environmental
Public Health Research Agenda, 2002–2010,
intended as a means of guiding research sup-
ported by the agency over the next decade,
the ATSDR addresses the issue of worker-to-
family exposures, which it says may con-
tribute substantially to total exposures to
hazardous substances in the environment.
The draft agenda cites three goals regarding
worker-to-family exposures: identify occupa-
tional practices associated with worker-to-
family exposures, determine the contribution
of worker-to-family exposure to total haz-
ardous environmental exposures and the
occurrence of adverse health outcomes, and
develop and evaluate interventions to pre-
vent such exposures. Suggested research
approaches include reviewing existing data-
bases to identify possible worker-to-family
exposure scenarios and developing health
education materials to educate workers about
the risks of carrying contaminants home.
After a century of widespread use, steps
are being taken to curb the use of Cr(VI) in
industry, but for many manufacturing
processes, Cr(VI) remains the chemical of
choice, thanks to its powerful anticorrosive
properties. Research on Cr(VI) is ongoing,
but there are still many questions to be
answered about the human health effects of
this industrial heavyweight. However, with a
growing base of results from recent studies,
the ever-expanding field of molecular epi-
demiology, and growing cooperation
between industry, research, and regulatory
agencies, maybe it won’t take another 100
years to find the answers.
Cheryl Pellerin
Susan M. Booker
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n 7 December 1987, officials from Pacific Gas and Electric
Company (PG&E), the world’s largest utility, advised
California regulatory authorities that they’d detected hexa-
valent chromium (Cr[VI]) at levels of 580
micrograms per liter (µg/L)—over 10 times
the state’s 50-µg/L limit for total chromium
in a groundwater monitoring well. Cr(VI)
was being used as an anticorrosive in the
cooling towers of a PG&E gas compressor
station in the Mojave Desert town of
Hinkley.
People who lived in Hinkley had experi-
enced a disturbing array of health problems:
liver, heart, respiratory, and reproductive
failure, cancer of the brain, kidney, breast,
uterus, and gastrointestinal system, Hodgkin
disease, frequent miscarriages, and more.
Were these problems related to the com-
pressor station’s wastewater ponds? PG&E
officials said no. But until 1972, PG&E had
knowingly released 370 million gallons of
Cr(VI)-contaminated wastewater into the
unlined ponds, and the toxic compound had
made its way into Hinkley’s groundwater.
In 1993, 77 Hinkley plaintiffs filed a law-
suit against PG&E. The suit was a direct result of a massive
communications effort mounted by Erin Brockovich, an
employee in a local law firm. She had uncovered the utility’s
environmental misconduct and launched a personal investi-
gation that ended in the largest settlement on record for a
civil class-action lawsuit. PG&E filed a motion to strike all
claims for preconception injuries (fear of cancer) as specula-
tive. But the plaintiffs—648 by the end—
ended up recovering for injury claims and
settling with PG&E for $333 million. In addi-
tion, PG&E agreed to stop using Cr(VI) and
clean up the contamination.
The case remains controversial among
chromium experts because most of the
Hinkley exposures involved drinking Cr(VI)-
laced water. This route of exposure is widely
believed to cause much less toxicity than
inhalational exposures because ingested
Cr(VI) is converted to inactive trivalent
chromium in the stomach. Many experts
also claim that the exposures were too low
to cause health effects, and that there are
few data linking Cr(VI) exposures to the
Hinkley residents’ symptoms. But others
counter that there are too many gaps in the
data on chromium to dismiss the Hinkley
residents’ case. They believe the fact that
this toxic form of chromium can enter all
types of cells means that scientists may yet
discover that it can damage many organ systems. Until more
is known about how different doses and routes of exposure
of Cr(VI) affect different populations, it is too soon to rule
out high drinking water exposures as a health risk.
Chromium hits the silver screen. Actress
Julia Roberts played the title character in Erin
Brockovich, a film based on the Hinkley case.
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Hexavalent Chromium: One Town’s Story